PTIX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Protagenic Therapeutics Inc (PTIX).


$3.33M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

PTIX Market Cap. (MRY)


PTIX Shares Outstanding (MRY)


PTIX Assets (MRY)


Total Assets

$1.96M

Total Liabilities

$942.76K

Total Investments

$0

PTIX Income (MRY)


Revenue

$0

Net Income

-$5.53M

Operating Expense

$5.70M

PTIX Cash Flow (MRY)


CF Operations

-$4.22M

CF Investing

$2.80M

CF Financing

$1.96M

PTIX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PTIX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,955,913 (-54.76%)

$4,323,369 (-46.21%)

$8,037,420 (-27.33%)

$11,059,923 (1157.89%)

Assets Current

$1,882,867 (-55.17%)

$4,200,037 (-47.73%)

$8,035,645 (-27.34%)

$11,059,923 (1157.89%)

Assets Non-Current

$73,046 (-40.77%)

$123,332 (6848.28%)

$1,775 (0%)

$0 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$1,013,154 (-72.38%)

$3,668,117 (-46.97%)

$6,917,558 (-30.42%)

$9,941,955 (964.72%)

Property Plant & Equipment Net

$73,046 (-40.77%)

$123,332 (6848.28%)

$1,775 (0%)

$0 (0%)

Cash & Equivalents

$1,838,469 (42.75%)

$1,287,893 (498.49%)

$215,189 (-60.24%)

$541,171 (-19.36%)

Accumulated Other Comprehensive Income

-$129,850 (-14.36%)

-$113,546 (83.23%)

-$676,907 (-172.56%)

-$248,349 (-44.74%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$2,768,119 (-64.34%)

$7,763,517 (-21.02%)

$9,830,085 (0%)

Investments Current

$0 (0%)

$2,768,119 (-64.34%)

$7,763,517 (-21.02%)

$9,830,085 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$942,759 (43.88%)

$655,252 (-15.52%)

$775,632 (-2.99%)

$799,535 (39.90%)

Accumulated Retained Earnings (Deficit)

-$36,303,216 (-17.95%)

-$30,777,872 (-19.40%)

-$25,777,375 (-16.00%)

-$22,221,870 (-25.55%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$344,230 (8.10%)

$318,433 (-76.82%)

Debt Current

$0 (0%)

$0 (0%)

$344,230 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$318,433 (-76.82%)

Total Liabilities

$942,759 (43.88%)

$655,252 (-41.49%)

$1,119,862 (0.17%)

$1,117,968 (-44.90%)

Liabilities Current

$942,759 (43.88%)

$655,252 (-41.49%)

$1,119,862 (40.06%)

$799,535 (22.03%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$318,433 (-76.82%)

PTIX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$1,758,609 (45.69%)

$1,207,107 (-38.68%)

$1,968,549 (-34.46%)

$3,003,623 (62.20%)

Research & Development Expense

$3,942,341 (18.75%)

$3,319,867 (108.90%)

$1,589,239 (39.80%)

$1,136,790 (62.45%)

Operating Expenses

$5,700,950 (25.93%)

$4,526,974 (27.24%)

$3,557,788 (-14.07%)

$4,140,413 (62.27%)

Interest Expense

$0 (0%)

$107,682 (-21.66%)

$137,456 (-72.34%)

$496,912 (101.85%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$5,525,344 (-10.50%)

-$5,000,497 (-40.64%)

-$3,555,505 (21.39%)

-$4,522,934 (-77.46%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$5,525,344 (-10.50%)

-$5,000,497 (-40.64%)

-$3,555,505 (21.39%)

-$4,522,934 (-77.46%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$5,525,344 (-10.50%)

-$5,000,497 (-40.64%)

-$3,555,505 (21.39%)

-$4,522,934 (-77.46%)

Weighted Average Shares

$4,899,953 (12.78%)

$4,344,580 (0.62%)

$4,317,875 (17.17%)

$3,685,206 (42.57%)

Weighted Average Shares Diluted

$4,899,953 (12.78%)

$4,344,580 (0.62%)

$4,317,875 (17.17%)

$3,685,206 (42.57%)

Earning Before Interest & Taxes (EBIT)

-$5,525,344 (-12.93%)

-$4,892,815 (-43.15%)

-$3,418,049 (15.10%)

-$4,026,022 (-74.85%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$5,700,950 (-25.93%)

-$4,526,974 (-27.24%)

-$3,557,788 (14.07%)

-$4,140,413 (-62.27%)

PTIX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$2,802,880 (-41.31%)

$4,775,482 (199.03%)

$1,596,974 (116.12%)

-$9,909,601 (0%)

Net Cash Flow from Financing

$1,963,546 (0%)

$0 (0%)

$0 (0%)

$12,577,664 (928.08%)

Net Cash Flow from Operations

-$4,216,517 (-13.84%)

-$3,703,776 (-85.76%)

-$1,993,814 (28.76%)

-$2,798,614 (-107.49%)

Net Cash Flow / Change in Cash & Cash Equivalents

$550,576 (-48.67%)

$1,072,704 (429.07%)

-$325,982 (-150.91%)

-$129,920 (-1.87%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$2,802,880 (-43.09%)

$4,925,257 (208.06%)

$1,598,779 (116.13%)

-$9,909,601 (0%)

Capital Expenditure

$0 (0%)

-$149,775 (-8197.78%)

-$1,805 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$1,963,546 (0%)

$0 (0%)

$0 (0%)

$12,250,539 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$667 (-33.17%)

$998 (-98.59%)

$70,858 (11129.48%)

$631 (129.17%)

Share Based Compensation

$923,139 (38.44%)

$666,828 (-22.88%)

$864,681 (-43.07%)

$1,518,756 (-8.22%)

Depreciation Amortization & Accretion

$50,286 (78.21%)

$28,218 (93960.00%)

$30 (0%)

$0 (0%)

PTIX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-474.60% (-366.21%)

-101.80% (-123.74%)

-45.50% (26.73%)

-62.10% (-121.33%)

Return on Average Assets (ROAA)

-294.30% (-258.03%)

-82.20% (-102.96%)

-40.50% (21.66%)

-51.70% (80.45%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-340335.30% (-330965.47%)

-102.80% (-142.45%)

-42.40% (41.68%)

-72.70% (87.10%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.43 (49.59%)

-0.86 (55.87%)

-1.95 (56.33%)

-4.47 (-6.38%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

3.29 (174.52%)

1.2 (19.70%)

1 (-57.66%)

2.36 (124.96%)

Debt to Equity Ratio (D/E)

0.93 (420.11%)

0.18 (10.49%)

0.16 (44.64%)

0.11 (106.35%)

Earnings Per Share (EPS)

-1.13 (1.74%)

-1.15 (-40.24%)

-0.82 (33.87%)

-1.24 (-24.00%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.86 (2.93%)

-0.89 (-91.99%)

-0.46 (39.13%)

-0.76 (-45.40%)

Book Value Per Share (BVPS)

0.21 (-75.47%)

0.84 (-47.32%)

1.6 (-40.62%)

2.7 (706.29%)

Tangible Assets Book Value Per Share (TABVPS)

0.4 (-59.90%)

0.99 (-46.53%)

1.86 (-37.99%)

3 (782.65%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (50.00%)

-2 (66.67%)

-6 (-20.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.41 (56.64%)

-0.96 (53.77%)

-2.07 (64.66%)

-5.86 (-20.41%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2 (-68.85%)

6.41 (-10.67%)

7.18 (-48.12%)

13.83 (930.77%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$4,216,517 (-9.42%)

-$3,853,551 (-93.10%)

-$1,995,619 (28.69%)

-$2,798,614 (-107.49%)

Enterprise Value (EV)

$2,273,657 (-51.18%)

$4,657,212 (-34.17%)

$7,074,557 (-70.00%)

$23,585,781 (110.58%)

Earnings Before Tax (EBT)

-$5,525,344 (-10.50%)

-$5,000,497 (-40.64%)

-$3,555,505 (21.39%)

-$4,522,934 (-77.46%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$5,475,058 (-12.55%)

-$4,864,597 (-42.32%)

-$3,418,019 (15.10%)

-$4,026,022 (-74.87%)

Invested Capital

-$825,315 (-134.67%)

$2,380,224 (-66.22%)

$7,046,599 (-29.80%)

$10,037,650 (983.08%)

Working Capital

$940,108 (-73.48%)

$3,544,785 (-48.74%)

$6,915,783 (-32.60%)

$10,260,388 (4479.30%)

Tangible Asset Value

$1,955,913 (-54.76%)

$4,323,369 (-46.21%)

$8,037,420 (-27.33%)

$11,059,923 (1157.89%)

Market Capitalization

$3,329,462 (-24.17%)

$4,390,781 (-36.50%)

$6,914,104 (-70.56%)

$23,483,807 (115.87%)

Average Equity

$1,164,286 (-76.30%)

$4,912,174 (-37.18%)

$7,819,320 (7.38%)

$7,282,024 (931.65%)

Average Assets

$1,877,469 (-69.15%)

$6,085,355 (-30.66%)

$8,776,128 (0.37%)

$8,743,828 (807.27%)

Invested Capital Average

$1,624 (-99.97%)

$4,758,187 (-40.97%)

$8,060,368 (45.62%)

$5,535,394 (1254.56%)

Shares

6,794,821 (53.20%)

4,435,132 (2.63%)

4,321,315 (1.94%)

4,238,954 (63.66%)